MONT-SAINT-HILAIRE, QUEBEC--(CCNMatthews - Aug. 10, 2006) - Axcan Pharma Inc. (TSX:AXP)(NASDAQ:AXCA) today reported financial results for the third quarter of fiscal 2006, ended June 30, 2006 (all amounts are stated in U.S. dollars). Highlights for the third quarter include: Strong revenue of $76.7 million representing a 29% increase compared to the same period in 2005, illustrating strength of core business. Fully diluted income per share increased 189% to $0.26, compared to the same period a year earlier. Revenue guidance for fiscal 2006 increased to $280-290 million.
